Healthcare Providers and Services
Company Overview of The University of Chicago Medical Center
The University of Chicago Medical Center operates as a hospital that provides healthcare services. It offers adoption, brain tumor, burn, and kidney stone services; aortic, celiac, esophageal, infectious, inflammatory bowel, kidney, liver, lung, pancreatic, Parkinson’s, and respiratory disease services; general, minimally invasive, orthopedic, plastic, thoracic, vascular, and weight loss surgery services; gastrointestinal, movement, and sleep disorder services; children’s, mental, pelvic, and women’s health services; and international patient, nursing, and urban health initiative programs. The company also provides cancer, cardiac, cold hands and polycystic ovary syndrome, dermatology, diabe...
5841 South Maryland Avenue
Chicago, IL 60637
Founded in 1927
Key Executives for The University of Chicago Medical Center
President of Medical Staff
Vice President and Chief Human Resources Officer
Executive Vice President for Medical Affairs
Compensation as of Fiscal Year 2014.
The University of Chicago Medical Center Key Developments
The University of Chicago Medical Center Announces Board Changes
Aug 8 14
The University of Chicago Medical Center added six new members to its governing Board of Trustees, and named a new president of the medical staff. Sandra Culbertson, MD, professor of obstetrics and gynecology and vice chair of clinical affairs, has been named president of the medical staff, replacing P. Allan Klock, Jr., MD. The new trustees are: James Abrams is chief operating officer at Medline Industries Inc. Prior to joining Medline, Abrams was an attorney with Kirkland and Ellis LLP. He earned his J.D. from the University of Chicago in 1987. Thomas J. Duckworth operates Stone Gate Venture Partners, a private investment firm, and previously worked for Goldman Sachs. Duckworth is vice president of the University of Chicago Cancer Research Foundation. Rachel Kohler, a principal at KoHop Ventures LLC. She was named to the University of Chicago's Board of Trustees in 2013. Earlier this year, Kohler was named chair of the board of directors of the MacLean Center for Clinical Medical Ethics at the university. William L. Morrison is president and chief operating officer of Northern Trust Corp., and is a director of Northern Trust Global Advisors. David (Duke) Reyes is chief executive of Reyes Beverage Group. James Stephen is executive chairman of Weber-Stephen Products LLC, a manufacturer of portable charcoal and gas grills. He is a member of the Visiting Committee to the Division of Biological Sciences and the Pritzker School of Medicine.
CollabRx, Inc. to Collaborate with The University of Chicago Medical Center on Clinical Cancer Sequencing and Interpretation
Jun 18 13
CollabRx, Inc. announced a collaboration with the thoracic oncology program at the University of Chicago Medical Center. The joint initiative will combine CollabRx content and technology resources with the results of genetic sequencing-based tests conducted at the University of Chicago Medical Center. The tests are designed to enable physicians to consider a tumor's unique genetic profile in cancer treatment planning. The collaboration will be led at the University of Chicago Medical Center by Ravi Salgia, MD, PhD, a professor of medicine and vice chair of translational research at the University of Chicago. Under the terms of the collaboration, CollabRx will provide a turnkey medical informatics solution by pairing the results of cancer mutational panels conducted by Dr. Salgia and colleagues at the medical center with clinically actionable and dynamically updated knowledge provided by CollabRx. Such knowledge includes the clinical impact of specific mutational profiles and associated therapeutic strategies such as drugs and clinical trials. It is also supported by CollabRx's large and growing network of over 75 leading experts and clinical practitioners in the U.S. and Europe. The medical informatics solution will be customized, for example, by taking into account the clinical experience of Dr. Salgia and colleagues as well as highlighting clinical trials at the University of Chicago for which patients may be eligible based on their tumor's genetic signature. Academic-based cancer treatment and research centers are among the earliest adopters of next-generation technologies to support clinical sequencing of tumors for the purpose of improving cancer treatment planning. The collaboration with the thoracic oncology program at the University of Chicago Medical Center is indicative of CollabRx's intent to provide to these top-tier cancer treatment centers a customized interpretive service paired with clinical genetic sequencing tests.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|